AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen operating income 1985–2026

Amgen's operating income in Q3 FY2026, the three months to 30 September 2026, was 3.71B USD, up 46.9% on the same quarter a year before. Amgen's operating income over the last twelve months was 12.61B USD, up 45.6% on the twelve months before. In fiscal year 2025 it was 9.08B USD, up 25.1% on the year before.

Last updated 12 Nov 2026 · Next report 2 Feb 2027

Operating income

Operating income · +0.7% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 202612.61B+45.63%32.39%28.80B73.97%18.17B
FY202531 Dec 20259.08B+25.10%24.71%26.01B70.80%16.90B
FY202431 Dec 20247.26B-8.09%21.71%20.57B61.53%13.36B
FY202331 Dec 20237.90B-17.45%28.01%19.78B70.15%14.80B
FY202231 Dec 20229.57B+25.23%36.34%19.92B75.66%12.17B
FY202131 Dec 20217.64B-16.41%29.40%19.53B75.16%11.30B
FY202031 Dec 20209.14B-5.53%35.95%19.27B75.77%13.00B
FY201931 Dec 20199.67B-5.74%41.41%19.01B81.35%12.63B
FY201831 Dec 201810.26B+2.91%43.22%19.65B82.73%12.88B
FY201731 Dec 20179.97B+1.83%43.65%18.78B82.19%12.86B
FY201631 Dec 20169.79B+15.63%42.60%18.83B81.90%12.53B
FY201531 Dec 20158.47B+36.81%39.10%17.44B80.49%11.18B
FY201431 Dec 20146.19B+5.52%30.86%15.64B77.96%8.75B
FY201331 Dec 20135.87B+5.20%31.41%15.33B82.08%7.57B
FY201231 Dec 20125.58B+29.34%32.30%14.35B83.10%7.15B
FY201131 Dec 20114.31B-22.24%27.67%13.16B84.42%5.82B
FY201031 Dec 20105.55B+0.71%36.84%12.83B85.25%6.94B
FY200931 Dec 20095.51B+5.60%37.60%12.55B85.72%6.83B
FY200831 Dec 20085.21B+31.01%34.75%12.71B84.70%6.64B
FY200731 Dec 20073.98B+3.65%26.94%12.22B82.75%5.98B
FY200631 Dec 20063.84B-20.79%26.91%12.17B85.32%6.03B
FY200531 Dec 20054.85B+44.80%39.00%10.35B83.25%5.69B
FY200431 Dec 20043.35B+8.31%31.73%8.82B83.59%4.64B
FY200331 Dec 20033.09B—36.99%7.02B83.96%3.78B
FY200231 Dec 2002-785.00M-151.27%-14.21%4.79B86.68%2.65B
FY200131 Dec 20011.53B+11.92%38.13%3.57B88.97%1.80B
FY200031 Dec 20001.37B+3.25%39.67%3.25B94.30%1.58B
FY199931 Dec 19991.33B+18.47%41.35%2.98B92.97%1.50B
FY199831 Dec 19981.12B+20.22%42.33%2.44B92.38%1.26B
FY199731 Dec 1997930.30M+1.56%39.66%2.16B92.17%1.05B
FY199631 Dec 1996916.00M+20.40%41.67%2.02B91.68%1.02B
FY199531 Dec 1995760.80M+8.92%39.96%1.72B90.09%845.00M
FY199431 Dec 1994698.50M+26.72%43.12%1.46B89.90%773.00M
FY199331 Dec 1993551.20M+10.66%40.68%1.19B87.50%601.90M
FY199231 Dec 1992498.10M+303.65%46.11%929.10M86.00%531.70M
FY199131 Dec 1991123.40M+141.49%18.15%588.60M86.58%144.90M
FY199031 Dec 199051.10M—26.84%175.70M92.28%68.80M
FY198831 Dec 1988-4.80M—-6.84%26.20M37.32%3.20M
FY198731 Dec 1987-5.60M—-12.64%8.80M19.86%-1.50M
FY198631 Dec 1986-1.40M—-4.70%8.00M26.85%1.20M
FY198531 Dec 1985-900.00K—-4.27%23.60M111.85%1.60M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Amgen's operating income

Source: Financial Modeling PrepVerified against SEC filings